Groowe Groowe / Newsroom / SNY
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

SNY News

Sanofi American Depositary Shares (Each representing one-half of one ordinary share)

Boston Globe to Host Health Equity Summit

prnewswire.com
JNJ SNY

IgG4-Related Disease Market Analysis and Forecasts, 2025-2026 & 2035 with Amgen, Zenas BioPharma, Bristol Myers Squibb, and Sanofi Leading

globenewswire.com
AMGN BMY SNY

Sanofi Supports AlphaDetect to Accelerate Detection of Alpha-1

prnewswire.com
SNY

American Kidney Fund and AKF Ambassadors on Capitol Hill for Annual AKF Kidney Action Summit

globenewswire.com
ALNY AMGN ARDX AZN BIIB CDTX CSL GSK NVS PFE SNY VRTX VTRS

Hemophilia Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

globenewswire.com
NVO PFE CSL SNY BMRN ALNY SANG BE REGN NTLA JNJ ABBV BMY TEO VRTX CRSP

AI in GxP Environments | 9-Hour Online Training Course - Provides Frameworks for Decision-Grade AI Implementation Vital for QA, Regulatory, and Governance Professionals

globenewswire.com
JNJ MRK SNY GSK

Mana.bio Announces Strategic Leadership Additions and Upcoming Presentation at ASGCT 2026 Annual Meeting

prnewswire.com
BNTX MRNA PFE SNY

Dupixent® (dupilumab) Demonstrates Improved Esophageal Function in Eosinophilic Esophagitis (EoE) Phase 4 Trial

globenewswire.com
SNY REGN

Hepatic Encephalopathy Market Set for Growth at a 1.2% CAGR Through 2036, Driven by Emerging Therapies and Rising Disease Burden | DelveInsight

globenewswire.com
VNDA GRFS BHC RDHL MRK TEVA PFE SNY LLY ABBV AZN CRCT SPRO CRNX

Recludix Pharma Announces Upcoming Oral Presentations on Preclinical Data for Oral STAT6 Inhibitor REX-8756 and Topical STAT 1/3 Inhibitors at the Society for Investigative Dermatology (SID) Annual Meeting

globenewswire.com
LLY SNY